stigmasterol and poriferasterol-monoglucoside

stigmasterol has been researched along with poriferasterol-monoglucoside* in 12 studies

Other Studies

12 other study(ies) available for stigmasterol and poriferasterol-monoglucoside

ArticleYear
Uptake and elimination of emerging polyfluoroalkyl substance F-53B in zebrafish larvae: Response of oxidative stress biomarkers.
    Chemosphere, 2019, Volume: 215

    6:2 chlorinated polyfluorinated ether sulfonate (F-53B) has been widely applied as a mist suppressant to replace perfluorooctane sulfonate (PFOS) in the metal plating industry in China for decades. Recently, F-53B has been frequently identified in the aquatic environment and wild-caught fish. However, studies on the uptake and elimination kinetics, and the toxicological effects of F-53B were very scarce. In this study, zebrafish larvae (72 h post fertilization, hpf) were exposed to F-53B (10, 100 μg/L) for 48 h, followed by a 24 h of depuration to examine both the dynamics of accumulation and elimination of F-53B and responses of antoxidant defense system in fish. The results showed that F-53B rapidly accumulated in zebrafish larvae in a concentration and time-dependent manner with BCF values of 3612-3615, but was eliminated slowly (half-life ranged from 241.5 to 258.6 h). F-53B exposure induced oxidative stress in zebrafish larvae, as reflected by the reduction in the GSH and MDA contents, CAT, SOD, CuZn-SOD, and GSH-ST activities, and the increase in GSH-Px activity as well as CAT and SOD protein levels. However, these oxidative stress markers were restored to control levels except for a decrease in protein level of SOD after depuration. Collectively, the results of this work indicate that F-53B behaves like PFOS and is bioaccumulative and persistent in zebrafish larvae, and further induced oxidative stress responses.

    Topics: Alkanesulfonates; Alkanesulfonic Acids; Animals; Biomarkers; China; Fluorocarbons; Larva; Oxidative Stress; Stigmasterol; Superoxide Dismutase; Water Pollutants, Chemical; Zebrafish

2019
Expression of poriferasterol monoglucoside associated with differentiation of Physarum polycephalum.
    The Journal of biological chemistry, 1987, Dec-05, Volume: 262, Issue:34

    A glycolipid which was expressed during a differentiation from haploid myxoamoebae to diploid plasmodia of a true slime mold, Physarum polycephalum, has been examined. In the amoeboid stage, cells did not contain this glycolipid, but after conjugation of the haploid cells, this substance appeared and increased in its amount. From structural studies of the purified glycolipid, it has been identified as poriferasterol monoglucoside.

    Topics: Cell Differentiation; Chemical Phenomena; Chemistry, Physical; Chromatography, Thin Layer; Glycolipids; Physarum; Phytosterols; Stigmasterol

1987
[USE OF ACTIVATED CHARCOAL FOR EXTRACTION OF SUBSTANCE EPI-F FROM CULTURE FLUID].
    Meditsinskaia promyshlennost' SSSR, 1963, Volume: 17

    Topics: Charcoal; Chemistry, Pharmaceutical; Cortisone; Culture Media; Pharmacy; Research; Stigmasterol

1963
[Observations on the changes of the serum protein picture in patients with cutaneous neoplasms undergoing treatment with Reichstein's substance F].
    Minerva dermatologica, 1959, Volume: 34

    Topics: Blood Proteins; Colchicine; Skin Neoplasms; Stigmasterol

1959
[Behavior and topical reactions of Reichstein's substance F in certain cutaneous zones].
    Minerva dermatologica, 1957, Volume: 32, Issue:8

    Topics: Colchicine; Skin; Stigmasterol

1957
[Clinical & histological observations on the results of radiotherapy with simultaneous use of Reichstein's substance F in skin diseases].
    Minerva dermatologica, 1957, Volume: 32, Issue:11

    Topics: Colchicine; Radiotherapy; Skin Diseases; Stigmasterol

1957
[Behavior of the electrophoretic picture & classic seroreactions in seroresistant latent syphilid after use of Reichstein's substance F].
    Minerva dermatologica, 1957, Volume: 32, Issue:12

    Topics: Administration, Cutaneous; Blood Proteins; Colchicine; Electrophoresis; Humans; Stigmasterol; Syphilis; Syphilis, Cutaneous

1957
[The local effects of an antimitotic (substance F) on malignant tumors of the uterine cervix and vulva].
    Annali di ostetricia e ginecologia, 1956, Volume: 78, Issue:9

    Topics: Antimitotic Agents; Colchicine; Female; Humans; Neoplasms; Stigmasterol; Uterine Cervical Neoplasms; Vulvar Neoplasms

1956
[Globular resistance of erythrocytes in acute, subacute and chronic poisoning by deacetylmethylcolchicine (substance F of Santavy and Reichstein); experimental study with rabbits].
    Archivio per le scienze mediche, 1955, Volume: 99, Issue:6

    Topics: Animals; Colchicine; Erythrocytes; Lagomorpha; Poisoning; Rabbits; Stigmasterol

1955
The optical crystallographic properties of some N.F.X substances.
    Journal of the American Pharmaceutical Association. American Pharmaceutical Association, 1955, Volume: 44, Issue:2

    Topics: Chemistry Techniques, Analytical; Crystallization; Crystallography; Stigmasterol

1955
[Demecolcin (substance F) a new alkaloid with strong antimitotic effect isolated from Colchicum autumnale].
    Klinische Wochenschrift, 1954, Jan-15, Volume: 32, Issue:3-4

    Topics: Alkaloids; Animals; Antimitotic Agents; Colchicine; Colchicum; Neoplasms, Experimental; Stigmasterol

1954
[Colchicine effect and granulocytopoiesis; clinical and experimental observations with substance F from Colchicum autumnale].
    Klinische Wochenschrift, 1953, Sep-01, Volume: 31, Issue:33-34

    Topics: Colchicine; Colchicum; Humans; Leukocytes; Stigmasterol

1953